Subtle cues can dictate the fate of stem cellsPhys.OrgInhibiting only GSK3-beta could also provide a useful tool for producing stem cells that are not merely "pluripotent" but able to contribute to the formation of embryos. These so-called na… Continue reading
UCSF News ServicesNew Immunotherapy for Deadly Childhood Brain Cancer Targets …UCSF News ServicesChildren with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of… Continue reading
Endpoints News |
Mustang Bio Launches CRISPR/Cas9 CAR–T Collaborations with Harvard, BIDMC
Genetic Engineering & Biotechnology News Mustang Bio said today it plans to develop CRISPR/Cas9-enhanced chimeric antigen receptor engineered T–cell (CAR-T) therapies for cancer through a license from Harvard University and a research collaboration agreement with Beth Israel Deaconess Medical … CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T … Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel … |
Endpoints News |
CRISPR/Cas9 pioneer Chad Cowan enlists in Mustang Bio’s CAR-T …
Endpoints News The tech race spawned by a blockbuster scramble to the top of the emerging CAR-T sector has inspired a tie-up between one of the pioneering scientists involved with CRISPR/Cas9 gene editing and an up-and-comer cancer drug developer that is working on a … Mustang Bio Launches CRISPR/Cas9 CAR-T Collaborations with Harvard, BIDMCGenetic Engineering & Biotechnology News Mustang Bio Announces License Agreement with Harvard University, and Research Collaboration with Beth Israel …Nasdaq |